|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
21 Aug 2025, 20:56
Kudos
Bookmarks
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism, where venture firms channel funds into emerging businesses, sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital, such as employee training or team-building programs, are viewed as costs rather than investments. Start-ups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
The primary purpose of the passage is to
A. highlight how limited mentoring and other resource gaps emerge under U.S. venture-funding pressures.
B. examine how short-term pressures in American venture funding can hinder the sustainable growth of startups.
C. argue that patient-capital models are universally superior to venture funding.
D. propose replacing traditional venture funding with publicly backed partnerships modeled on Finland.
E. explain why nations with diversified portfolios avoid valuation swings.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital, such as employee training or team-building programs, are viewed as costs rather than investments. Start-ups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
The primary purpose of the passage is to
A. highlight how limited mentoring and other resource gaps emerge under U.S. venture-funding pressures.
B. examine how short-term pressures in American venture funding can hinder the sustainable growth of startups.
C. argue that patient-capital models are universally superior to venture funding.
D. propose replacing traditional venture funding with publicly backed partnerships modeled on Finland.
E. explain why nations with diversified portfolios avoid valuation swings.
21 Aug 2025, 20:56
Kudos
Bookmarks
Official Solution:
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism, where venture firms channel funds into emerging businesses, sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital, such as employee training or team-building programs, are viewed as costs rather than investments. Start-ups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
The primary purpose of the passage is to
A. highlight how limited mentoring and other resource gaps emerge under U.S. venture-funding pressures.
B. examine how short-term pressures in American venture funding can hinder the sustainable growth of startups.
C. argue that patient-capital models are universally superior to venture funding.
D. propose replacing traditional venture funding with publicly backed partnerships modeled on Finland.
E. explain why nations with diversified portfolios avoid valuation swings.
A) Incorrect: The choice singles out mentoring/resource gaps, whereas the passage critiques a broader short-term mindset that affects many dimensions of startup growth.
B) Correct Answer: The passage examines how short-term pressures in U.S. venture funding can undermine sustainable growth, contrasting this with more patient models abroad. This matches the passage goal.
C) Incorrect: It overstates the author’s view; the passage expressly notes there is “no consensus” that patient capital is universally superior.
D) Incorrect: The author does not advocate fully replacing venture funding; he calls for balance, not wholesale substitution.
E) Incorrect: Diversified national portfolios and macro-level valuation swings are outside the passage’s scope.
Answer: B
The system used by American venture capitalists is often lauded for its dynamism, high risk tolerance, and capacity for swift scaling. Yet a body of longitudinal research suggests that the same model often encourages short-term exits, limiting the scope for sustainable growth. Indeed, data indicate that U.S. venture funding has soared in recent years, reflecting an unprecedented appetite for brisk expansions. This market-driven allocation mechanism, where venture firms channel funds into emerging businesses, sometimes prioritizes rapid valuations over long-term viability. However, no consensus exists on whether patient capital always outperforms aggressive scaling. In contrast, some analyses show that countries such as Finland rely more heavily on public-private partnerships that foster strategic mentorship and steady capital infusions, allowing entrepreneurs to refine their products and cultivate enduring customer bases. American investors, holding diversified stakes in many early-stage companies, often lack the bandwidth for deep, ongoing evaluations. As a result, they rely on immediate metrics such as monthly user growth, overshadowing broader indicators like robust team development or resilient supply chains. Consequently, valuations can fluctuate wildly in response to brief changes in consumer demand, fueling risky behavior and misallocation of capital toward trendy sectors while leaving potentially transformative, slower-growing fields underfunded.
This short-term focus also influences how founders allocate their internal resources. Managers often justify outlays through traditional financial models grounded in near-term performance, reminiscent of the “by-the-numbers” approach described in widely cited management studies. When quick profitability becomes paramount, expenditures on human capital, such as employee training or team-building programs, are viewed as costs rather than investments. Start-ups commonly pare back mentorship initiatives and long-term research projects to preserve immediate cash flow, aiming to satisfy venture boards and protect valuations. In countries emphasizing patient capital, by contrast, firms enjoy greater freedom to cultivate intangible assets that underpin lasting growth. According to a recent study, ventures receiving patient financing were likelier to pursue research projects. While the American venture-capital system undoubtedly propels many enterprises to rapid prominence, its short horizon can sow precarious conditions for both investors and companies. True competitiveness arises when businesses balance swift expansion with ongoing capability enhancement, ensuring that innovation endures beyond fleeting market cycles. This approach not only fosters long-term stability but also safeguards stakeholders’ interests by promoting consistent innovation, strategic resource utilization, and a more resilient entrepreneurial ecosystem overall.
The primary purpose of the passage is to
A. highlight how limited mentoring and other resource gaps emerge under U.S. venture-funding pressures.
B. examine how short-term pressures in American venture funding can hinder the sustainable growth of startups.
C. argue that patient-capital models are universally superior to venture funding.
D. propose replacing traditional venture funding with publicly backed partnerships modeled on Finland.
E. explain why nations with diversified portfolios avoid valuation swings.
A) Incorrect: The choice singles out mentoring/resource gaps, whereas the passage critiques a broader short-term mindset that affects many dimensions of startup growth.
B) Correct Answer: The passage examines how short-term pressures in U.S. venture funding can undermine sustainable growth, contrasting this with more patient models abroad. This matches the passage goal.
C) Incorrect: It overstates the author’s view; the passage expressly notes there is “no consensus” that patient capital is universally superior.
D) Incorrect: The author does not advocate fully replacing venture funding; he calls for balance, not wholesale substitution.
E) Incorrect: Diversified national portfolios and macro-level valuation swings are outside the passage’s scope.
Answer: B
